-
CYT Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Cyteir Therapeutics (CYT)
Company Profile
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 129.24 mm | 129.24 mm | 129.24 mm | 129.24 mm | 129.24 mm | 129.24 mm |
Cash burn (monthly) | 1.46 mm | 2.05 mm | 1.72 mm | 3.19 mm | 1.52 mm | 2.15 mm |
Cash used (since last report) | 24.99 mm | 35.05 mm | 29.41 mm | 54.40 mm | 25.92 mm | 36.67 mm |
Cash remaining | 104.25 mm | 94.19 mm | 99.83 mm | 74.84 mm | 103.33 mm | 92.57 mm |
Runway (months of cash) | 71.2 | 45.9 | 57.9 | 23.5 | 68.0 | 43.1 |
13F holders | Current |
---|---|
Total holders | 48 |
Opened positions | 15 |
Closed positions | 21 |
Increased positions | 8 |
Reduced positions | 15 |
13F shares | Current |
---|---|
Total value | 84.93 mm |
Total shares | 24.73 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Novo Holdings A/S | 4.84 mm | $14.47 mm |
FMR | 3.87 mm | $11.58 mm |
Venrock Associates VII | 3.26 mm | $0.00 |
Baker Bros. Advisors | 2.64 mm | $7.90 mm |
Osage University GP II | 2.47 mm | $28.14 mm |
OUP Management | 2.47 mm | $7.40 mm |
Avidity Partners Management | 1.85 mm | $5.53 mm |
Vanguard | 611.60 k | $1.83 mm |
Newtyn Management | 606.25 k | $1.81 mm |
Laurion Capital Management | 359.50 k | $1.08 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
20 Mar 24 | Braden Michael Leonard | Common Stock, par value $0.001 per share | Buy | Acquire P | Yes | No | 2.95 | 170,589 | 503.24 k | 3,654,053 |
18 Mar 24 | Braden Michael Leonard | Common Stock, par value $0.001 per share | Buy | Acquire P | Yes | No | 3.01 | 113,777 | 342.47 k | 3,483,464 |
4 Mar 24 | Markus MD Renschler | Common Stock | Option exercise | Acquire M | No | No | 1.69 | 6,304 | 10.65 k | 1,103,661 |
4 Mar 24 | Markus MD Renschler | Stock Option Common Stock | Option exercise | Dispose M | No | No | 1.69 | 6,304 | 10.65 k | 220,648 |
4 Mar 24 | David G Gaiero | Common Stock | Option exercise | Acquire M | No | No | 1.69 | 2,373 | 4.01 k | 102,391 |
4 Mar 24 | David G Gaiero | Stock Option Common Stock | Option exercise | Dispose M | No | No | 1.69 | 2,373 | 4.01 k | 83,052 |
29 Feb 24 | Markus MD Renschler | Common Stock | Option exercise | Acquire M | No | No | 1.2 | 2,537 | 3.04 k | 1,097,357 |
29 Feb 24 | Markus MD Renschler | Common Stock | Option exercise | Acquire M | No | No | 1.69 | 12,607 | 21.31 k | 1,094,820 |
29 Feb 24 | Markus MD Renschler | Stock Option Common Stock | Option exercise | Dispose M | No | No | 1.2 | 2,537 | 3.04 k | 0 |
29 Feb 24 | Markus MD Renschler | Stock Option Common Stock | Option exercise | Dispose M | No | No | 1.69 | 12,607 | 21.31 k | 226,952 |